Francis Brasseur

Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group.

S. Burchill, F. Brasseur, U. Keilholz, 1998, European journal of cancer.

A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma

F. Brasseur, T. Boon, B. J. Van den Eynde, 1996, The Journal of experimental medicine.

Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines

F. Brasseur, P. Bruggen, M. Dullaers, 2005, Gene Therapy.

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

M. Probst-Kepper, B. Monsarrat, F. Brasseur, 2000, Immunity.

Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.

F. Brasseur, P. Bruggen, T. Boon, 1999, Journal of immunology.

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N- acetylglucosaminyltransferase V gene

F. Brasseur, C. Viret, T. Boon, 1996, The Journal of experimental medicine.